FDA clears algorithms for cardiac ablation from CathVision
CathVision announced that it received FDA clearance for its PVI Analyzer and Signal Complexity algorithms as part of its Cardialytics suite.
Source: massdevice.com
Stay updated with breaking news from Denmark Based Cathvision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CathVision announced that it received FDA clearance for its PVI Analyzer and Signal Complexity algorithms as part of its Cardialytics suite.
Electrophysiology (EP) technology developer CathVision announced today that it secured $7.2 million in funding from existing investors.